Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Market Vectors Pharmaceutical ETF

+ Add to Watchlist

VEFV:GR

66.6200 EUR 0.3300 0.49%

As of 13:35:29 ET on 05/26/2015.

Snapshot for Market Vectors Pharmaceutical ETF (VEFV)

Open: 66.9400 High - Low: 67.1100 - 66.3500 Primary Exchange: Berlin
Volume: 0 52-Week Range: 43.7400 - 68.5700 Beta vs MVPPHTR: 1.0020

ETF Chart for VEFV

No chart data available.
  • VEFV:GR 66.6200
  • 1D
  • 1M
  • 1Y
66.9500
Interactive VEFV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for VEFV

Market Vectors Pharmaceutical ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to track the performance of the US Listed Pharmaceutical 25 Index.

Inception Date: 2009-03-20 Telephone: 1-212-293-2000
Managers: PETER LIAO / GEORGE CAO
Web Site: www.vaneck.com

Fundamentals for VEFV

NAV -
Assets (M) (on 2015-05-21) 377.1092
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for VEFV

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2015-04-01) 0.4975
Dividend Yield (ttm) 1.51%

Performance for VEFV

1-Month -0.57% 1-Year +53.66%
3-Month +8.19% 3-Year +36.00%
Year To Date +25.70% 5-Year -
Expense Ratio 0.35

Top Fund Holdings for VEFV

Filing Date: 05/21/2015
Name Position Value % of Total
Novartis AG 339,832 35,610,995 9.468%
Johnson & Johnson 305,062 31,244,450 8.307%
Pfizer Inc 712,940 24,496,618 6.513%
Novo Nordisk A/S 376,721 21,710,431 5.772%
Sanofi 369,332 18,928,265 5.032%
Valeant Pharmaceuticals Intern 80,532 18,785,700 4.994%
Merck & Co Inc 309,173 18,581,297 4.940%
AbbVie Inc 275,508 18,087,100 4.809%
Actavis plc 59,181 17,826,501 4.739%
GlaxoSmithKline PLC 379,846 17,305,784 4.601%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil